Home » Newsletters » BioWorld Science

BioWorld Science

July 25, 2000

View Archived Issues

Genentech moves products forward in Q2 2000

BCY Ventures selects lead compound for CF therapy

Inhaled furosemide reduces experimental dyspnea in humans

Brasofensine coadministered with levodopa/carbidopa in PD patients

Phase I trial of edaravone further defines pharmacokinetic profile

Extended intervention time interval demonstrated for AM-36

Renally impaired subjects tolerate AMP-579 well, without dose adjustment

Linear pharmacokinetics, good tolerance reported for SKP-450 in healthy volunteers

Atosiban effectively and safely delays preterm birth; major European launch reported

Fujisawa seeks Canadian approval of tacrolimus ointment; FDA reschedules advisory committee meeting

Preclinical results for NCX-2216 support its development for Alzheimer's disease

SmithKline Beecham submits sNDA for Paxil for use in PTSD

Antiinflammatory drug candidate acquired by Discovery Therapeutics advances to phase II

Vion begins phase I trial of intravenous TAPET at Royal Marsden Hospital

Immunoconjugates claimed by Progenics for treatment, diagnosis of AIDS

Recently issued patent covers new Haemophilus vaccines

New allogeneic cancer vaccines in development at Onyvax

Peptides synthesized at Eisai modulate active oxygen production in neutrophils

Fujisawa presents new series of hypoglycemic agents

Compounds for beta3-adrenoceptor-related disorders designed at Asahi

Chemokine CCR3 receptor modulators claimed by DuPont in recent patent literature

Chiron halts clinical development of rhIGF-I in osteoarthritis

DPC-681 and DPC-684, new HIV protease inhibitors selected as clinical candidates

Arrow Therapeutics and Triangle Pharmaceuticals establish collaboration for antiviral agents

Neurocrine and Taisho complete final agreement; preliminary phase I data for NBI-6024 promising

Photofrin distribution agreement established

Pharmacyclics updates Xcytrin clinical trial progress

Licensing opportunity from NIH: polypeptides binding with HIV-1 gp120

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 20, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...